BFA
AMRI

BlackRock Fund Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

BlackRock Fund Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$48.8M Buy
2,599,221
+359,629
+16% +$6.11M 0.01% 1701
2016
Q3 		$37M Buy
2,239,592
+39,317
+2% +$582K 0.01% 1775
2016
Q2 		$29.6M Buy
2,200,275
+72,249
+3% +$1.05M 0.01% 1818
2016
Q1 		$32.5M Buy
2,128,026
+17,274
+0.8% +$271K 0.01% 1711
2015
Q4 		$41.9M Sell
2,110,752
-22,764
-1% -$433K 0.01% 1591
2015
Q3 		$37.2M Buy
2,133,516
+236,473
+12% +$4.81M 0.01% 1608
2015
Q2 		$38.4M Buy
1,897,043
+57,894
+3% +$1.12M 0.01% 1701
2015
Q1 		$32.4M Buy
1,839,149
+104,831
+6% +$1.79M 0.01% 1794
2014
Q4 		$28.2M Buy
1,734,318
+105,970
+7% +$1.94M 0.01% 1856
2014
Q3 		$35.9M Buy
1,628,348
+109,289
+7% +$2.24M 0.01% 1572
2014
Q2 		$30.6M Buy
1,519,059
+484,445
+47% +$8.21M 0.01% 1744
2014
Q1 		$19.2M Buy
1,034,614
+18,488
+2% +$255K 0.01% 2025
2013
Q4 		$10.2M Buy
1,016,126
+4,879
+0.5% +$59K ﹤0.01% 2374
2013
Q3 		$13M Buy
1,011,247
+125,175
+14% +$1.54M ﹤0.01% 2204
2013
Q2 		$10.5M Buy
+886,072
New +$9.6M ﹤0.01% 2239

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $911M AUM 0.66% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

BlackRock Fund Advisors's AMRI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Albany Molecular Research Inc (AMRI) stake by 16% in Q4 2016, buying an estimated $6.11M and bringing the position to 2,599,221 shares worth $48.8M. The position accounts for 0.01% of the portfolio, ranked #1701.

BlackRock Fund Advisors first reported a position in AMRI in Q2 2013 and has held it in 15 quarters since. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • BlackRock Fund Advisors held 2,599,221 shares of Albany Molecular Research Inc worth $48.8M as of Q4 2016.
  • BlackRock Fund Advisors bought 359,629 Albany Molecular Research Inc shares in Q4 2016, an estimated $6.11M.
  • Albany Molecular Research Inc made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1701 holding.
  • BlackRock Fund Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and has held it in 15 quarters since.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.